Effects of transdermal estrogen administration on peripheral vascular responsiveness in menopausal women
Tóm tắt
This study was designed to evaluate the peripheral vascular responses to acute estrogen replacement. According to a cross-over, double-blind study design, we randomized nine healthy postmenopausal women (time lapse from menopause to >1 year; mean age±SD 45.4±11.7 years) to treatment with transdermal patches of estradiol-17β or matched placebo. The estrogen patch was rated to assure a plasma concentration of substance of more than 100 pg/ml after 8–10 hours of treatment. Forearm blood flow (ml/100 ml/minute), local vascular resistance (mmHg/ml/100 ml/minute), venous volume (ml/100 ml), and venous compliance (ml/100 ml/mmHg) were measured in supine resting subjects by the straingauge venous occlusion plethysmography. Plasma concentration of norepinephrine (pg/ml) was quantified by HPLC-ED. Estradiol-17β produced increase in forearm blood flow and decrease in local vascular resistance. The drug reduced circulating norepinephrine concentrations. There were no significant changes in mean arterial pressure or heart rate. Venous volume and venous compliance were both enhanced by estrogen administration. The peripheral circulatory changes are attributed to a direct activity of estradiol-17β on arterial and venous wall and may in part reflect a modulation of estrogen on peripheral sympathetic tone.
Tài liệu tham khảo
Magness RR, Rosenfeld CR (1989) Local and systemic estradiol-17β: Effects on uterine and systemic vasodilation. Am J Physiol 256:E536-E542.
Jiang C, Sarrel PM, Lindsay CD, Poole-Wilson PA, Collins P (1991) Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 104:1033–1037.
Kondo K, Okuno T, Eguchi T (1980) Vascular action of high dose estrogen in rats. Endocrinol Jpn 27:307–313.
McCalden TA (1975) The inhibitory action of oestradiol-17β and progesterone on venous smooth muscle. Br J Pharmacol 53:183–192.
Granger KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S (1991) Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 338:839–842.
Sarrel PM, Lindsay D, Rosano GMC, Poole-Wilson PA (1992) Angina and normal coronary arteries in women: Gynecologic findings. Am J Obstet Gynecol 167:467–472.
Stampfer MJ, Colditz GA, Willett WC, et al. (1991) Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 325:756–762.
Rossetti ZL, Mercuro G, Rivano AC (1983) A study of the parameters affecting flow gradient analysis of catecholamines, Dopa and Dopac by ion pair liquid chromatography with electrochemical detection. Life Sci 33:2387–2397.
Giannessi P, Zucchelli GC, Simonini N, Piro MA, Masini S, Malvano R (1978) Methodological validation of human chorionic somatomammotropin, estriol, estradiol and progesterone radioimmunoassay in pregnancy. J Nucl Med Allied Sci 22:71.
Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH (1987) Menopause and the risk of coronary heart disease in women. N Engl J Med 316:1105–1110.
Lobo RA (1990) Cardiovascular implications of estrogen replacement therapy. Obstet Gynecol 74(suppl 4):18S-25S.
Bush TL, Barrett-Connor E, Cowan LD (1987) Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study. Circulation 75:1102–1109.
Adams MR, Clarkson TB, Kaplan JR, Koritnik DR (1990) Ovarian secretions and atherosclerosis. In: Ovarian Secretion and Cardiovascular and Neurological Function. Naftolin F, Gutmann JN, DeChemey AH, et al. (eds). Raven Press: New York, pp 151–159.
Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM (1991) Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196–1204.
Wren BG (1992) The effect of oestrogen on the female cardiovascular system. Med J Aust 156(3):204–208.
Bartelink ML, Wollersheim H, Theeuwes A, van Duren D, Thien T (1990) Changes in skin blood flow during the menstrual cycle: The influence of the menstrual cycle on the peripheral circulation in healthy female volunteers. Clin Sci 78(5):527–532.
Williams JK, Adams MR, Klopfenstein HS (1990) Estrogen modulates responses of atherosclerotic coronary arteries. Circ Res 81:1680–1687.
Jiang C, Sarrel PM, Poole-Wilson PA, Collins P (1992) Acute effect of β17-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 263:H271-H275.
Jones SB, Bylund DB, Rieser CA (1983) α2-Adrenergic receptors binding in human platelets: Alterations during the menstrual cycle. Clin Pharmacol Ther 34:90–96.
Stowell LI, McIntosh CJ, Cooke R (1988) Adrenoceptor and imipramine receptor binding during the menstrual cycle. Acta Psychiatr Scand 78:366–368.
Iversen LL (1973) Catecholamine uptake processes. Br Med Bull 29:130–135.
Owens JF, Stoney CM, Matthews KA (1993) Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation 88:2794–2802.
Colucci WS, Gimbrone MA, McLaughlin MK (1982) Increased vascular catecholamine sensitivity and α-adrenergic receptor affinity in female and estrogen-treated male rats. Circ Res 50:805–811.
Sarrel PM (1990) Ovarian hormones and the circulation. Maturitas 12(3):287–298.
Brass LM, Kisiel D, Sarrel PM (1990) Correlation between estrogen and middle cerebral artery blood velocity at different times in the menstrual cycle in women with catamenial migraines. J Cardiovasc Technol 9:68.
De Ziegler D, Bessis R, Frydman R (1991) Vascular resistance of uterine arteries: Physiological effects of estradiol and progesterone. Fertil Steril 55(4):775–779.
Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P (1993) Beneficial effects of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342:133–136.